InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Monday, 09/20/2021 10:04:44 AM

Monday, September 20, 2021 10:04:44 AM

Post# of 198123
ENZC The Company is in active production of anti-CoronaVirus fully human monoclonal antibodies in its Texas lab. The monoclonal antibodies being produced target multiple specific epitopes on the virus. To be effective, monoclonal antibodies produced against viruses must target immutable, conserved epitopes (sequences) on the virus or the antibodies will be ineffective due to virus mutation.

With this information, the Company is producing fully human monoclonal antibodies targeting these sites. Early in 2021, the Company filed patent applications claiming these 19 conserved CoronaVirus epitope sites and its methodology for the production of such antibodies.

much more info here:

https://enzolytics.com/company-news/

I don't call people names or use vulgar language in Public or Private. Once you cuss and call someone names you lost the argument and also lost your class. You have nothing else left to defend your comment. Statements are my Opinion only. Do your own DD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News